相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanoparticles as new tools for inhibition of cancer angiogenesis
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
A hypoxia- and telomeraseresponsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma
Eonju Oh et al.
SCIENTIFIC REPORTS (2018)
Designer Oncolytic Adenovirus: Coming of Age
Alexander T. Baker et al.
CANCERS (2018)
Combing oncolytic adenovirus expressing Beclin-1 with chemotherapy agent doxorubicin synergistically enhances cytotoxicity in human CML cells in vitro
Li Li et al.
ACTA PHARMACOLOGICA SINICA (2018)
An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation
Zhao Liu et al.
HUMAN GENE THERAPY (2017)
Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy
Eonju Oh et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence
Nasser Hashemi Goradel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy
Shuwen Li et al.
ONCOLOGY LETTERS (2017)
Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
So Young Kim et al.
ONCOTARGET (2017)
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
Sadia Zafar et al.
ONCOIMMUNOLOGY (2017)
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy
Riikka Havunen et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
Irene Kuhn et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
Anwen Howells et al.
FRONTIERS IN ONCOLOGY (2017)
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment
Lukasz Kuryk et al.
PLOS ONE (2017)
Forgotten public health impacts of cancer - an overview
Susana Viegas et al.
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2017)
A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response
Bo-Kyeong Jung et al.
BIOMATERIALS (2017)
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Hong Jiang et al.
CANCER RESEARCH (2017)
Immune Checkpoint Inhibitors: An Innovation in Immunotherapy for the Treatment and Management of Patients with Cancer
Jennifer Dine et al.
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING (2017)
Recent advances in genetic modification of adenovirus vectors for cancer treatment
Yuki Yamamoto et al.
CANCER SCIENCE (2017)
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
Cristian Capasso et al.
ONCOIMMUNOLOGY (2016)
Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy
Jianhua Chen et al.
ACS NANO (2016)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol et al.
CLINICAL CANCER RESEARCH (2016)
Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models
Roma Yumul et al.
HUMAN GENE THERAPY (2016)
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity
Mariangela Garofalo et al.
MOLECULAR CANCER THERAPEUTICS (2016)
CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells
Yang Li et al.
VIRUS RESEARCH (2016)
Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
Jing Li Huang et al.
BIOMEDICINES (2016)
Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration
Joung-Woo Choi et al.
ACTA BIOMATERIALIA (2015)
Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus
Mari Hirvinen et al.
HUMAN GENE THERAPY (2015)
Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L
Guang-yao Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans
Simona Bramante et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Polymeric oncolytic adenovirus for cancer gene therapy
Joung-Woo Choi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Oncolytic Replication of E1b-Deleted Adenoviruses
Pei-Hsin Cheng et al.
VIRUSES-BASEL (2015)
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Hanni Uusi-Kerttula et al.
VIRUSES-BASEL (2015)
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy
Oana Draghiciu et al.
ONCOIMMUNOLOGY (2015)
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
Mikko Siurala et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas
Dong-xu Zhao et al.
CELLULAR IMMUNOLOGY (2014)
Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors
Estrella Lopez-Gordo et al.
HUMAN GENE THERAPY (2014)
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans
Simona Bramante et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Oncolytic adenoviruses: A thorny path to glioma cure
I. V. Ulasov et al.
GENES & DISEASES (2014)
Oncolytic Adenoviruses in Cancer Treatment
Ramon Alemany
BIOMEDICINES (2014)
An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells
Lin Fang et al.
MOLECULAR MEDICINE REPORTS (2013)
IL-21 in cancer immunotherapy: At the right place at the right time
Saskia J. A. M. Santegoets et al.
ONCOIMMUNOLOGY (2013)
Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production
Barbara Iovine et al.
CANCER LETTERS (2012)
A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
James R. Tysome et al.
CLINICAL CANCER RESEARCH (2012)
Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
J. D. Dias et al.
GENE THERAPY (2012)
TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy
Jeffrey P. Marcoe et al.
NATURE IMMUNOLOGY (2012)
Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer
Rui Wang et al.
ONCOLOGY REPORTS (2012)
An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine
M. Bhattacharyya et al.
CANCER GENE THERAPY (2011)
Phase I Trial of TGF-beta 2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine
Jairo Olivares et al.
CLINICAL CANCER RESEARCH (2011)
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Chen-Nen Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
A Novel Combination Treatment of Armed Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Radiotherapy in Murine Hepatocarcinoma
Wonwoo Kim et al.
JOURNAL OF RADIATION RESEARCH (2011)
Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
Song-Nan Zhang et al.
MOLECULAR THERAPY (2011)
Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
Erica B. Wilson et al.
PLOS ONE (2011)
Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer
Manabu Onimaru et al.
CANCER LETTERS (2010)
Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
Vincenzo Cerullo et al.
CANCER RESEARCH (2010)
Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
I-K Choi et al.
GENE THERAPY (2010)
CCR6 Recruits Regulatory T Cells and Th17 Cells to the Kidney in Glomerulonephritis
Jan-Eric Turner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model
Christof Renner et al.
MOLECULAR CANCER (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
Anniina Koski et al.
MOLECULAR THERAPY (2010)
Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro
Alessandra Curioni Fontecedro et al.
VIROLOGY JOURNAL (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo
Stephan Leitner et al.
CLINICAL CANCER RESEARCH (2009)
Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4+ T-cell-independent CD8+ T-cell-mediated tumor control
Maria R. Sorensen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Replicating and non-replicating viral vectors for vaccine development
Marjorie Robert-Guroff
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Transforming growth factor-β and the immune response:: Implications for anticancer therapy
Stephen H. Wrzesinski et al.
CLINICAL CANCER RESEARCH (2007)
Clinical trials with oncolytic adenovirus in China
Wang Yu et al.
CURRENT CANCER DRUG TARGETS (2007)
Reversing tumor immune suppression with intratumoral IL-12:: Activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors
Mehmet O. Kilinc et al.
JOURNAL OF IMMUNOLOGY (2006)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Development of nonhuman adenoviruses as vaccine vectors
DS Bangari et al.
VACCINE (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus
M Perreau et al.
JOURNAL OF VIROLOGY (2005)
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
E Contardi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Tumor necrosis factor, cancer and anticancer therapy
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini et al.
CANCER RESEARCH (2004)
Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial
Wei Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Adenovirus structure
JJ Rux et al.
HUMAN GENE THERAPY (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency
TC Liu et al.
MOLECULAR THERAPY (2004)
GM-CSF-secreting melanoma vaccines
G Dranoff
ONCOGENE (2003)
The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses
G Trinchieri et al.
IMMUNITY (2003)
Prospects for CD40-directed experimental therapy of human cancer
AW Tong et al.
CANCER GENE THERAPY (2003)
Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma
LX Zhang et al.
MOLECULAR THERAPY (2002)
Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in α-fetoprotein-producing human liver cancer cells
J Kim et al.
CANCER LETTERS (2002)
Bak and Bax function to limit adenovirus replication through apoptosis induction
A Cuconati et al.
JOURNAL OF VIROLOGY (2002)
Reciprocal activating interaction between natural killer cells and dendritic cells
F Gerosa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
S Ries et al.
BRITISH JOURNAL OF CANCER (2002)
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12
M Barajas et al.
HEPATOLOGY (2001)
Update an adenovirus and its vectors
WC Russell
JOURNAL OF GENERAL VIROLOGY (2000)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Canine adenovirus vectors: an alternative for adenovirus mediated gene transfer
EJ Kremer et al.
JOURNAL OF VIROLOGY (2000)
分享论文
